Logo image of AAB.CA

ABERDEEN INTERNATIONAL INC (AAB.CA) Stock Fundamental Analysis

TSX:AAB - Toronto Stock Exchange - CA0030691012 - Common Stock - Currency: CAD

0.03  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AAB. AAB was compared to 83 industry peers in the Capital Markets industry. Both the profitability and financial health of AAB have multiple concerns. AAB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AAB has reported negative net income.
In the past year AAB had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AAB reported negative net income in multiple years.
In multiple years AAB reported negative operating cash flow during the last 5 years.
AAB.CA Yearly Net Income VS EBIT VS OCF VS FCFAAB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

The Return On Assets of AAB (-47.79%) is worse than 82.14% of its industry peers.
Looking at the Return On Equity, with a value of -61.91%, AAB is doing worse than 78.57% of the companies in the same industry.
Industry RankSector Rank
ROA -47.79%
ROE -61.91%
ROIC N/A
ROA(3y)-56.63%
ROA(5y)-31.03%
ROE(3y)-68.42%
ROE(5y)-37.95%
ROIC(3y)N/A
ROIC(5y)N/A
AAB.CA Yearly ROA, ROE, ROICAAB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

AAB's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of AAB has grown nicely.
The Profit Margin and Operating Margin and Gross Margin are not available for AAB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y31.72%
OM growth 5Y1.77%
PM growth 3Y31.72%
PM growth 5Y1.88%
GM growth 3YN/A
GM growth 5YN/A
AAB.CA Yearly Profit, Operating, Gross MarginsAAB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100 200 300 400

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, AAB has about the same amount of shares outstanding.
Compared to 5 years ago, AAB has more shares outstanding
AAB has a worse debt/assets ratio than last year.
AAB.CA Yearly Shares OutstandingAAB.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
AAB.CA Yearly Total Debt VS Total AssetsAAB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -4.84, we must say that AAB is in the distress zone and has some risk of bankruptcy.
AAB has a Altman-Z score of -4.84. This is amonst the worse of the industry: AAB underperforms 80.95% of its industry peers.
AAB has a debt to FCF ratio of 3.50. This is a good value and a sign of high solvency as AAB would need 3.50 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.50, AAB belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
AAB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, AAB belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 3.5
Altman-Z -4.84
ROIC/WACCN/A
WACCN/A
AAB.CA Yearly LT Debt VS Equity VS FCFAAB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

AAB has a Current Ratio of 0.22. This is a bad value and indicates that AAB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.22, AAB is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
AAB has a Quick Ratio of 0.22. This is a bad value and indicates that AAB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AAB (0.22) is worse than 80.95% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
AAB.CA Yearly Current Assets VS Current LiabilitesAAB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 60.07% over the past year.
The Revenue has grown by 73.14% in the past year. This is a very strong growth!
EPS 1Y (TTM)60.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%141.11%
Revenue 1Y (TTM)73.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%157.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AAB.CA Yearly Revenue VS EstimatesAAB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M
AAB.CA Yearly EPS VS EstimatesAAB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AAB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AAB.CA Price Earnings VS Forward Price EarningsAAB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

AAB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AAB is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 401.32
EV/EBITDA N/A
AAB.CA Per share dataAAB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AAB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ABERDEEN INTERNATIONAL INC

TSX:AAB (3/7/2025, 7:00:00 PM)

0.03

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)12-12 2024-12-12
Earnings (Next)06-10 2025-06-10
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap4.78M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF 401.32
P/OCF 401.32
P/B 0.43
P/tB 0.43
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.25%
OCF(TTM)0
OCFY0.25%
SpS-0.03
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.79%
ROE -61.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM -0.29%
ROA(3y)-56.63%
ROA(5y)-31.03%
ROE(3y)-68.42%
ROE(5y)-37.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y31.72%
OM growth 5Y1.77%
PM growth 3Y31.72%
PM growth 5Y1.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover-0.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 3.5
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z -4.84
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%141.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)73.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%157.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y60.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y100.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y100.18%
OCF growth 3YN/A
OCF growth 5YN/A